News

Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following ...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), announces the company will attend the 2025 EAACI Congress in Glasgow, UK, on June 13-16.
Anaphylaxis is an acute, whole-body allergic reaction that happens very quickly in some people after exposure to certain medicines, foods or insect stings. Symptoms include a rapid and weak pulse, a ...
“Some people don’t take [their] food allergies seriously and they’re risk takers, and then others are paralyzed by their food ...
Learn when rashes signal medical emergencies. Color, location, and symptoms reveal dangerous conditions needing urgent care.
Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...
Gayathiri Jeyatheesan, 28, died at Aintree University Hospital on January 25 this year, shortly after eating crab meat. The ...
Five million Australians have allergies. For some, it’s a matter of life and death. What causes them? Can they be prevented?
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...
Distinctive whistling sounds during breathing and wheezing may signal serious allergic reactions that require prompt medical evaluation ...
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...